HopeStage
Back to all studies
CompletedNCT01160991

Olanzapine, Amisulpride, and Glucose Use in Schizophrenia

About this titleRead the official source — NCT01160991
Medication studyAges 18–65Germany
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
MannheimSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2004
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
Central Institute of Mental Health, Mannheim
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Procedure
Locations
Germany
Age range
From 18 Years to 65 Years
Official registry ID
NCT01160991
Official title
Show the full official title

Effects of the Serotonin 2A Receptor on Insulin Sensitivity and Secretion: a Double-blind Controlled Comparison of Olanzapine vs. Amisulpride:

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Mannheim

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Amisulpride, Olanzapine and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies